# HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism

> **NCT02354079** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 435 (actual)

## Conditions studied

- Hypobetalipoproteinemia

## Interventions

- **GENETIC:** hypobetalipoproteinemia genetic and genotypic screening

## Key facts

- **NCT ID:** NCT02354079
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-01-07
- **Primary completion:** 2022-01-07
- **Final completion:** 2032-01-07
- **Target enrollment:** 435 (ACTUAL)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02354079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02354079, "HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02354079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*